1. Home
  2. ONCY vs GRRR Comparison

ONCY vs GRRR Comparison

Compare ONCY & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • GRRR
  • Stock Information
  • Founded
  • ONCY 1998
  • GRRR 2001
  • Country
  • ONCY Canada
  • GRRR United Kingdom
  • Employees
  • ONCY N/A
  • GRRR N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • GRRR Computer Software: Prepackaged Software
  • Sector
  • ONCY Health Care
  • GRRR Technology
  • Exchange
  • ONCY Nasdaq
  • GRRR Nasdaq
  • Market Cap
  • ONCY 86.1M
  • GRRR 85.6M
  • IPO Year
  • ONCY 1999
  • GRRR N/A
  • Fundamental
  • Price
  • ONCY $0.76
  • GRRR $12.18
  • Analyst Decision
  • ONCY Strong Buy
  • GRRR Buy
  • Analyst Count
  • ONCY 2
  • GRRR 1
  • Target Price
  • ONCY $4.00
  • GRRR $13.00
  • AVG Volume (30 Days)
  • ONCY 359.4K
  • GRRR 2.1M
  • Earning Date
  • ONCY 11-12-2024
  • GRRR 12-27-2024
  • Dividend Yield
  • ONCY N/A
  • GRRR N/A
  • EPS Growth
  • ONCY N/A
  • GRRR N/A
  • EPS
  • ONCY N/A
  • GRRR 2.28
  • Revenue
  • ONCY N/A
  • GRRR $78,940,347.00
  • Revenue This Year
  • ONCY N/A
  • GRRR $12.29
  • Revenue Next Year
  • ONCY N/A
  • GRRR $21.40
  • P/E Ratio
  • ONCY N/A
  • GRRR $4.50
  • Revenue Growth
  • ONCY N/A
  • GRRR 424.97
  • 52 Week Low
  • ONCY $0.76
  • GRRR $2.09
  • 52 Week High
  • ONCY $1.53
  • GRRR $13.00
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 26.96
  • GRRR 83.99
  • Support Level
  • ONCY $0.91
  • GRRR $5.75
  • Resistance Level
  • ONCY $0.88
  • GRRR $8.24
  • Average True Range (ATR)
  • ONCY 0.04
  • GRRR 1.05
  • MACD
  • ONCY -0.01
  • GRRR 0.44
  • Stochastic Oscillator
  • ONCY 11.12
  • GRRR 95.89

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.

About GRRR Gorilla Technology Group Inc. Ordinary shares

Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.

Share on Social Networks: